Tekla Capital Management LLC lessened its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 50.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 53,250 shares of the company’s stock after selling 53,250 shares during the quarter. Tekla Capital Management LLC’s holdings in Express Scripts were worth $5,059,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in ESRX. Abrams Capital Management L.P. bought a new position in Express Scripts during the 2nd quarter worth approximately $204,846,000. Canada Pension Plan Investment Board lifted its holdings in Express Scripts by 124.5% during the 2nd quarter. Canada Pension Plan Investment Board now owns 1,971,200 shares of the company’s stock worth $152,196,000 after buying an additional 1,093,200 shares during the last quarter. FMR LLC lifted its holdings in Express Scripts by 72.0% during the 3rd quarter. FMR LLC now owns 2,442,388 shares of the company’s stock worth $232,051,000 after buying an additional 1,022,548 shares during the last quarter. BlackRock Inc. lifted its holdings in Express Scripts by 1.5% during the 2nd quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock worth $2,735,103,000 after buying an additional 538,578 shares during the last quarter. Finally, Korea Investment CORP lifted its holdings in Express Scripts by 153.7% during the 2nd quarter. Korea Investment CORP now owns 830,263 shares of the company’s stock worth $64,105,000 after buying an additional 503,000 shares during the last quarter. 85.02% of the stock is currently owned by institutional investors.
In related news, Director Mahon Thomas P. Mac sold 5,234 shares of the firm’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total value of $520,783.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.79% of the stock is owned by company insiders.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The business had revenue of $25.56 billion for the quarter, compared to the consensus estimate of $25.11 billion. During the same quarter last year, the business posted $2.51 EPS. The business’s revenue was up 3.6% on a year-over-year basis. On average, research analysts forecast that Express Scripts Holding Co will post 9.08 earnings per share for the current year.
A number of research firms have commented on ESRX. Zacks Investment Research reaffirmed a “buy” rating and set a $109.00 target price on shares of Express Scripts in a report on Tuesday, November 13th. Barclays raised their price target on Express Scripts from $83.00 to $90.00 and gave the stock an “equal weight” rating in a report on Thursday, November 1st. Maxim Group reissued a “hold” rating on shares of Express Scripts in a report on Thursday, November 1st. William Blair downgraded Express Scripts from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 31st. Finally, Royal Bank of Canada set a $101.00 price target on Express Scripts and gave the stock a “buy” rating in a report on Thursday, November 1st. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $90.60.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
See Also: Preferred Stock
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.